Related Experiment Videos
Interactions between group B streptococci and human cord blood lymphocytes
H J Tietz1, R Gantenberg, E Halle
1Department of Medical Microbiology, Humboldt University, Berlin.
Summary
Group B streptococci readily interact with human cord blood lymphocytes, significantly increasing their proliferation. This interaction, crucial for understanding neonatal immunity, appears common across various strains.
Area of Science:
- Immunology
- Microbiology
- Neonatal Health
Background:
- Group B streptococci (Streptococcus agalactiae) are a leading cause of invasive infections in neonates.
- Understanding the interaction between Group B streptococci and the neonatal immune system is critical for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the interaction between different Group B streptococcal strains and human mononuclear cells (MNC).
- To analyze the adherence of Group B streptococci to lymphocytes and their effect on lymphocyte proliferation in neonates and adults.
Main Methods:
- Analysis of bacterial adherence to human peripheral lymphocytes.
- Assessment of lymphocyte proliferation in cultured adult and neonatal MNC upon addition of Group B streptococci.
- Measurement of [3H]thymidine incorporation to quantify cellular proliferation.
Main Results:
- Group B streptococcal strains (Ib/c, III/x, B variant) adhered to neonatal cord blood lymphocytes, bound by specific lymphoid cells.
- Neonatal MNC cultures showed an approximately 8-fold increase in lymphocyte proliferation when exposed to Group B streptococci.
- Adult MNC exhibited minimal response in terms of streptococcal binding and proliferation, unlike neonatal cells.
Conclusions:
- Group B streptococci exhibit a common ability to interact with and activate human cord blood lymphocytes.
- The observed interaction and lymphocyte activation are independent of bacterial serotype and origin.
- These findings highlight a unique susceptibility of the neonatal immune system to Group B streptococci.